Clinical Trials Logo

Clinical Trial Summary

Background: The atrial fibrillation cycle length (AFCL) measured by electrophysiologic study is well known parameter for the maintenance of sinus rhythm after DC cardioversion (DCCV) or ablation therapy. The aim of this study was to test whether a AFCL measured by transesophageal echocardiography (AFCLTEE) could predict the outcome after DCCV.

Methods: In 100 consecutive patients with non-valvular AF, TEE will be performed within 6 hours before DCCV. The AFCLTEE was measured by averaging 10 sequential peak to peak intervals of atrial fibrillary waves seen in the pulsed wave Doppler image on the left atrial appendage. The primary endpoint was AF free survival rate at 6 months after DCCV.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03496272
Study type Observational
Source Pusan National University Yangsan Hospital
Contact Yong Hyun Park, MD
Phone 82-55-360-2363
Email nadroj@pusan.ac.kr
Status Recruiting
Phase
Start date January 1, 2017
Completion date June 30, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT02864758 - Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France
Not yet recruiting NCT03397602 - Exercise Training in Patients With Persistent or Permanent Atrial Fibrillation N/A
Not yet recruiting NCT03258645 - This Study Uses the SITS Registry to Find Out When Patients With a Heart Rhythm Disorder (Atrial Fibrillation) Start Treatment With Dabigatran After They Had a Stroke
Recruiting NCT03313167 - Screening for Atrial Fibrillation (AF)-Potential Patients to Increase AF Detection Rate
Enrolling by invitation NCT03259373 - IMplementation of an RCT to imProve Treatment With Oral AntiCoagulanTs in Patients With Atrial Fibrillation N/A
Completed NCT02878213 - DURABLE-I Study: Dielectric Unravelling of Radiofrequency ABLation Effectiveness N/A
Not yet recruiting NCT03455673 - Exclusion of Intra-atrial Thrombus Before Catheter Ablation
Not yet recruiting NCT03564327 - Clinical Prognosis of Patients With Atrial Fibrillation Non-reducible or Non-inducible During Radiofrequency Ablation
Not yet recruiting NCT03620656 - The Validation of the FibriCheck Application for the Detection of Atrial Fibrillation
Not yet recruiting NCT03503812 - Mitigating the Health Effects of Desert Dust Storms Using Exposure-Reduction Approaches N/A
Not yet recruiting NCT03243175 - Avoiding Anticoagulation After IntraCerebral Haemorrhage Phase 3
Not yet recruiting NCT02808260 - Predicting Development of SCAF in Device Patients
Not yet recruiting NCT03645564 - Impact of the Information Follow-up Given to Patients on Their Disease Understanding and Therapeutic Adherence in Patients Under Direct Oral Anticoagulants and With Atrial Fibrillation in a Cardiology Department N/A
Not yet recruiting NCT03489096 - Cryoballoon Targeting Atrial Fibrosis in Atrial Fibrillation N/A
Recruiting NCT02892578 - Systematic Screening With Electrocardiogram for Unknown Atrial Fibrillation in 65 Years Old and Above People in Nursing Home N/A
Recruiting NCT02916550 - Breathing Intervention for Cardiac Anxiety N/A
Recruiting NCT02923414 - Comparison of High Versus Escalating Shocks in Cardioverting Atrial Fibrillation N/A
Recruiting NCT02914860 - Comparison of the Ganglionated Plexi Activity in Patients With Different Forms of Atrial Fibrillation Guided by SUMO Technology Phase 1/Phase 2
Recruiting NCT02896595 - General Anesthesia With ETT vs LMA in Patients Undergoing Ablation for Atrial Fibrillation N/A
Recruiting NCT02982434 - The New Pharmaceutical Composition Containing Botulinum Toxin to Treat Atrial Fibrillation Phase 2